Kopran's Q1 FY 2025-26 Quarterly Results

Result Summary

• Kopran Ltd reported a 29.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 3.0%.
• Its expenses for the quarter were down by 25.0% QoQ and up 0.4% YoY.
• The net profit decreased 60.0% QoQ and decreased 32.9% YoY.
• The earnings per share (EPS) of Kopran Ltd stood at 2 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Kopran Ltd is an established pharmaceutical company primarily involved in the development, manufacturing, and marketing of a broad range of pharmaceutical products. The company's product line includes formulations and active pharmaceutical ingredients (APIs) that cater to both domestic and international markets. Kopran Ltd operates within the pharmaceutical industry, which is characterized by rigorous regulatory standards and significant research and development investments. Recent developments in the company or industry are not detailed in the provided information, and additional research would be required to address any major occurrences or strategic shifts.

Revenue

For Q1FY26, Kopran Ltd reported a Total Income of ₹137.77 crores, reflecting a decrease compared to both the previous quarter and the same quarter in the previous year. Specifically, the Total Income saw a quarter-over-quarter (QoQ) decline of 29.6% from ₹195.75 crores in Q4FY25. Year-over-year (YoY), Total Income decreased by 3.0% from ₹142.06 crores in Q1FY25. The decline in revenue on a QoQ basis suggests a significant reduction in the company's income over the last quarter. The YoY figures indicate a slight reduction in total revenue when compared to the same period last year.

Profitability

Kopran Ltd's Profit Before Tax for Q1FY26 was ₹9.89 crores, marking a substantial decrease from ₹25.18 crores in Q4FY25, representing a 60.7% decline. Additionally, compared to Q1FY25, where Profit Before Tax stood at ₹14.73 crores, there was a YoY decrease of 32.9%. Similarly, Profit After Tax for Q1FY26 was ₹7.45 crores, down from ₹18.62 crores in Q4FY25, which is a 60.0% decrease. From a YoY perspective, Profit After Tax decreased by 32.9% from ₹11.10 crores in Q1FY25. Earnings Per Share (EPS) for Q1FY26 was ₹2.00, dropping 48.7% QoQ from ₹3.90 and 13.0% YoY from ₹2.30. These figures highlight a notable reduction in profitability across the board, both on a quarterly and yearly basis.

Operating Metrics

Kopran Ltd's Total Expenses for Q1FY26 were ₹127.89 crores, which decreased by 25.0% from ₹170.57 crores in Q4FY25. Compared to Q1FY25, where expenses were ₹127.32 crores, there was a minimal increase of 0.4% YoY. The Tax for Q1FY26 was ₹2.44 crores, down 62.8% from ₹6.56 crores in Q4FY25, and 33.0% from ₹3.64 crores in Q1FY25. These operating metrics suggest a reduction in expenses QoQ, with a slight increase YoY, while tax outflow saw significant reductions in both comparisons. The data provided offers a snapshot of the company's cost management and tax obligations over the recent periods.